أوكساتومايد

Chemical data

Formula

C27H30N4O

Molecular weight

426.6 g/mol

IUPAC name

3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one

SMILES

C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5

InChIKey

BAINIUMDFURPJM-UHFFFAOYSA-N

XLogP

4.1

Polar surface area

38.8 Ų

H-bond donors

1

H-bond acceptors

3

Formal charge

0

via PubChem

Drug data · ChEMBL

Max clinical phase

Phase 2

Molecule type

Small molecule

Indications

allergic disease, Duchenne muscular dystrophy

via ChEMBL · EBI

• Oxatomide for stable asthma in adults and children.The Cochrane database of systematic reviews · 2003
• Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy.Drugs · 1984
• Antiinflammatory effects of oxatomide.Journal of investigational allergology & clinical immunology · 1999
• [Oxatomide: review of pharmacodynamic effects and clinical effects in dermatology].Allergie et immunologie · 1990
• [Protective effect of oxatomide in infantile bronchial asthma. Double-blind study vs placebo].Minerva pediatrica · 1998

via PubMed

Wikidata facts

Subclass of

chemical compound

Mass

426.242

via Wikidata · CC0